DE3752250T2 - Cyclohexan-Derivate, sie enthaltende Zusammensetzungen und ihre Verwendung - Google Patents

Cyclohexan-Derivate, sie enthaltende Zusammensetzungen und ihre Verwendung

Info

Publication number
DE3752250T2
DE3752250T2 DE3752250T DE3752250T DE3752250T2 DE 3752250 T2 DE3752250 T2 DE 3752250T2 DE 3752250 T DE3752250 T DE 3752250T DE 3752250 T DE3752250 T DE 3752250T DE 3752250 T2 DE3752250 T2 DE 3752250T2
Authority
DE
Germany
Prior art keywords
compositions containing
cyclohexane derivatives
compounds
cyclohexane
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3752250T
Other languages
English (en)
Other versions
DE3752250D1 (de
Inventor
Matti Siren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Perstorp AB
Original Assignee
Perstorp AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp AB filed Critical Perstorp AB
Publication of DE3752250D1 publication Critical patent/DE3752250D1/de
Application granted granted Critical
Publication of DE3752250T2 publication Critical patent/DE3752250T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE3752250T 1986-11-26 1987-11-26 Cyclohexan-Derivate, sie enthaltende Zusammensetzungen und ihre Verwendung Expired - Fee Related DE3752250T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8605063A SE8605063D0 (sv) 1986-11-26 1986-11-26 Derivatives of cyclohexane

Publications (2)

Publication Number Publication Date
DE3752250D1 DE3752250D1 (de) 1999-03-18
DE3752250T2 true DE3752250T2 (de) 1999-06-24

Family

ID=20366413

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3752250T Expired - Fee Related DE3752250T2 (de) 1986-11-26 1987-11-26 Cyclohexan-Derivate, sie enthaltende Zusammensetzungen und ihre Verwendung
DE19873740152 Withdrawn DE3740152A1 (de) 1986-11-26 1987-11-26 Cyclohexanderivate und zusammensetzungen, welche diese enthalten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19873740152 Withdrawn DE3740152A1 (de) 1986-11-26 1987-11-26 Cyclohexanderivate und zusammensetzungen, welche diese enthalten

Country Status (11)

Country Link
US (2) US5157140A (de)
EP (1) EP0269105B1 (de)
JP (1) JP2528149B2 (de)
AT (1) ATE176474T1 (de)
AU (1) AU603158B2 (de)
CA (1) CA1339660C (de)
DE (2) DE3752250T2 (de)
ES (1) ES2130111T3 (de)
GB (2) GB2198135B (de)
GR (1) GR3030124T3 (de)
SE (1) SE8605063D0 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8605063D0 (sv) * 1986-11-26 1986-11-26 Matti Siren Derivatives of cyclohexane
US5274161A (en) * 1986-11-26 1993-12-28 Perstorp Ab Derivatives of cyclohexane
EP0579957A1 (de) 1987-07-02 1994-01-26 3i RESEARCH EXPLOITATION LIMITED Herstellung von Isomeren von Myoinositolderivaten
GB8715558D0 (en) * 1987-07-02 1987-08-12 Research Corp Ltd Isomers of myoinositol derivatives
ES2095985T3 (es) * 1991-06-26 1997-03-01 Hoechst Ag Analogos de fosfato de inositol como sustancias antagonistas del calcio.
SE9102068L (sv) * 1991-07-03 1993-01-04 Perstorp Ab Derivat av inositol, kompositioner innehaallande dessa samt anvaendning daerav
SE502990C2 (sv) * 1993-11-22 1996-03-04 Perstorp Ab Användning av en inositoltrisfosfatester för beredning av ett smärtstillande läkemedel
SE503122C2 (sv) * 1993-11-22 1996-03-25 Perstorp Ab Användning av en inositoltrisfosfatester för behandling av inflammatoriska tillstånd
SE502989C2 (sv) * 1993-11-22 1996-03-04 Perstorp Ab Användning av en inositoltrisfosfatester för beredning av läkemedel
SE510914C2 (sv) * 1995-12-21 1999-07-05 Perstorp Ab Användning av en ester av inositoltrisfosfat för beredning av läkemedel
SE9602463D0 (sv) * 1996-06-24 1996-06-24 Perstorp Ab The use of growth factor modulating compounds
US20030147937A1 (en) * 2000-04-12 2003-08-07 Thomas Schwarz Use of compatible solutes as substances having free radical scavenging properties
WO2002015868A2 (de) * 2000-08-18 2002-02-28 Bitop Gesellschaft Für Biotechnische Optimierung Mbh Kosmetische formulierung enthaltend mindestens ein di-zuckeralkoholphosphat von c3 bis c6 zuckeralkoholen
EP1345950A4 (de) 2000-11-21 2005-04-27 Inologic Inc Inositderivate zur erhöhung der chloridsezernierung und als entzündungshemmer
AU2003216424A1 (en) 2002-02-25 2003-10-08 Guilford Pharmaceuticals, Inc. Phosphorus-containing compounds with polymeric chains, and methods of making and using the same
WO2004087721A1 (en) * 2003-03-27 2004-10-14 Inologic, Inc. Camphanylidene and phenylalkyl inositol polyphosphate compounds, compositions, and methods of their use
MX2009009126A (es) * 2007-03-01 2009-10-28 Concourse Health Sciences Llc Isomeros de niacinato de inositol y usos de los mismos.
JP4925461B2 (ja) * 2007-12-25 2012-04-25 株式会社錢高組 鋼管を使用した土留め構造体、その構築方法及びシールドマシンの発進到達工法
GB0920985D0 (en) * 2009-11-30 2010-01-13 Queen Mary & Westfield College Novel inositol phosphate derivatives
WO2013045107A1 (en) * 2011-09-29 2013-04-04 Eth Zurich Pharmaceutical compounds for use in the therapy of clostridium difficile infection
US9751903B2 (en) 2011-09-29 2017-09-05 Eth Zurich Pharmaceutical compounds for use in the therapy of clostridium difficile infection
EP3386548B1 (de) * 2015-12-11 2021-03-17 ETH Zürich Inositolderivate zur verwendung bei pathologischer kristallisation
US11028112B2 (en) 2015-12-11 2021-06-08 Eth Zurich Inositol derivatives for use in pathological crystallization
US11707470B2 (en) 2015-12-11 2023-07-25 Eth Zurich Inositol derivatives for use in pathological crystallization
CA3006701C (en) * 2015-12-11 2023-12-12 Mattias IVARSSON 4,6-di-(o-thiophosphate)-inositol-1,2,3,5-tetra-o-sulfate for c. difficile infection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1604995A (en) * 1968-12-27 1972-06-26 Metal inositol hexaphosphates - from inositol hexaphosphoric acid and organo metal cpd in anhydrous medium
SE465951B (sv) * 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
DE3783694T2 (de) * 1986-03-11 1993-05-19 Mitsui Toatsu Chemicals Verfahren zur herstellung von myoinositolabkoemmlingen.
SE8605063D0 (sv) * 1986-11-26 1986-11-26 Matti Siren Derivatives of cyclohexane
US4873355A (en) * 1987-05-29 1989-10-10 E. I. Du Pont De Nemours And Company Process for regioselectively preparing phosphorylated inositols and other cyclitols
JPS63198642U (de) * 1987-06-11 1988-12-21

Also Published As

Publication number Publication date
EP0269105A2 (de) 1988-06-01
GR3030124T3 (en) 1999-07-30
JPS63198694A (ja) 1988-08-17
DE3752250D1 (de) 1999-03-18
GB2198135B (en) 1991-07-31
US5278332A (en) 1994-01-11
ES2130111T3 (es) 1999-07-01
US5157140A (en) 1992-10-20
GB8727482D0 (en) 1987-12-23
GB2198135A (en) 1988-06-08
AU8168287A (en) 1988-06-02
AU603158B2 (en) 1990-11-08
ATE176474T1 (de) 1999-02-15
DE3740152A1 (de) 1988-06-09
CA1339660C (en) 1998-02-03
GB8727483D0 (en) 1987-12-23
JP2528149B2 (ja) 1996-08-28
EP0269105A3 (de) 1990-05-02
EP0269105B1 (de) 1999-02-03
SE8605063D0 (sv) 1986-11-26

Similar Documents

Publication Publication Date Title
DE3752250D1 (de) Cyclohexan-Derivate, sie enthaltende Zusammensetzungen und ihre Verwendung
CS782686A2 (en) Method of benzimidazole derivatives production
NZ236589A (en) A-nor-steroid-3-carboxylic acid derivatives and pharmaceutical compositions
IL109526A0 (en) Benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
DK77090D0 (da) Immunmodulerende azaspiraner
PH20806A (en) Dihydrobenzopyran derivatives,pharmaceutical composition containing them and method of use thereof
EP0614913A3 (de) Dynorphin Derivate.
ES8801232A1 (es) Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxolicas.
HUT52511A (en) Process for producing new substituted cephalosporine-sulfon derivatives and pharmaceutical compositions containing them as active components
ATE69807T1 (de) Phenoxyessigsaeure-verbindungen, ihre herstellung, pharmazeutische zusammensetzungen und deren verwendung.
DE3882895D1 (de) Imid-derivate, ihre herstellung und verwendung.
DE69331003D1 (de) Kristalle von derivaten von chinozon carbonsäure-hydraten
ATE129501T1 (de) Griseolsäurederivate, ihre herstellung und ihre verwendung.
DK240184D0 (da) Beta-carboline-3-carboxylic acid derivatives and method of preparing the same
DE3574969D1 (de) Aetheroxidderivate von zyklopropylphenolen.
DE3853958D1 (de) Substituierte Pyridin-Verbindungen, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
DE3677857D1 (de) 2,5-dimethylpyrrolderivative, ihre herstellung und ihre verwendung.
GR3001463T3 (en) Taurine derivative, its preparation and pharmaceutical compositions containing it
FI903531A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-imino-3-heterosyklyylialkyylibentsotiatsoliinijohdannaisten valmistamiseksi
ATE40118T1 (de) Benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel.
ES2009209A6 (es) Procedimiento para la obtencion de dihidropiridinlactoles.
DE69103025D1 (de) 2-imino-6-polyfluoralkyl-3-heterocyclylalkyl-benzothiazolinderivate, ihre herstellung und sie enthaltende arzneimittel.
DE3672635D1 (de) Esterderivate von 2,2-dimethyl-3-ethenylcyclopropancarbonsaeure, ihre herstellung, ihre verwendung als parasitizide und sie enthaltende zusammensetzungen.
DE3784883D1 (de) Fluor enthaltende makrolid-verbindungen, pharmazeutische zusammensetzungen, welche diese enthalten und ihre verwendung fuer die herstellung von arzneimitteln.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee